Smart Immune
Description
Smart Immune is a clinical-stage biotechnology company developing ProTcell, a thymus-
empowered T cell progenitor platform to rapidly re-arm the immune system against cancer and
infection. The company aims to radically improve outcomes for patients in hematology and
immuno-oncology. SMART101 is in Phase I/II trials for patients with acute leukemia or severe
combined immunodeficiencies (SCID), in the EU and the US. Additional clinical applications are
planned to be evaluated in combination with innovative cancer therapies.
Company members
On site for the event: Cristina Claver-Sicilia (market access project managerà , Jeremy Gaillard (CFO&CBO), and Karine Rossignol (CEO&Co-founder)